IN HB1184 | 2024 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 9 2024 - 25% progression, died in committee
Action: 2024-01-09 - First reading: referred to Committee on Public Health
Pending: House Public Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Breakthrough therapies. Establishes the breakthrough therapies research fund. Provides that a drug, biological product, or medical device that has been designated as a breakthrough therapy under federal law may be made available to a qualified patient and offered by a physician as a part of the patient's medical treatment. Specifies that a civil or criminal cause of action is not created against a manufacturer or health care provider for any harm to a qualified patient resulting from use of an investigational drug, biological product, or device.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Breakthrough therapies.

Sponsors


History

DateChamberAction
2024-01-09HouseFirst reading: referred to Committee on Public Health
2024-01-09HouseAuthored by Representative Moed

Indiana State Sources


Bill Comments

feedback